Assay Detail
Functional
CHEMBL5505499
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Antiviral activity against SARS CoV-2 USA-WA1/2020 infected in African green monkey Vero E6 cells assessed as reduction in viral plaque formation incubated for 3 days by plaque reduction neutralization assay
2
Total Activities
2
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Severe acute respiratory syndrome coronavirus 2 |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Target
SARS-CoV-2 (CHEMBL4303835) ↗| Type | ORGANISM |
| Organism | Severe acute respiratory syndrome coronavirus 2 |
Publication
New Strategies for Responding to SARS-CoV-2: The Present and Future of Dual-Target Drugs.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| EC50 | 2 | 5.07 | 5.08 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL445177 | GINGKOLIC ACID | — | 1 | 5.08 |
| CHEMBL33778 | ANACARDIC ACID | — | 1 | 5.05 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL445177 | GINGKOLIC ACID | EC50 | = | 8300.0 | nM | 5.08 |
| CHEMBL33778 | ANACARDIC ACID | EC50 | = | 9000.0 | nM | 5.05 |